These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 32149455)
1. CD11b is a novel alternate receptor for CD154 during alloimmunity. Liu D; Ford ML Am J Transplant; 2020 Aug; 20(8):2216-2225. PubMed ID: 32149455 [TBL] [Abstract][Full Text] [Related]
2. Differential induction of donor-reactive Foxp3 Liu D; Yao H; Ferrer IR; Ford ML Am J Transplant; 2024 Aug; 24(8):1369-1381. PubMed ID: 38552961 [TBL] [Abstract][Full Text] [Related]
3. CD8+CD122+PD-1+ Tregs Synergize With Costimulatory Blockade of CD40/CD154, but Not B7/CD28, to Prolong Murine Allograft Survival. Liu H; Qiu F; Wang Y; Zeng Q; Liu C; Chen Y; Liang CL; Zhang Q; Han L; Dai Z Front Immunol; 2019; 10():306. PubMed ID: 30863408 [TBL] [Abstract][Full Text] [Related]
5. The CD154-CD40 T cell costimulation pathway is required for host sensitization of CD8(+) T cells by skin grafts via direct antigen presentation. Zhai Y; Shen XD; Gao F; Coito AJ; Wasowska BA; Salama A; Schmitt I; Busuttil RW; Sayegh MH; Kupiec-Weglinski JW J Immunol; 2002 Aug; 169(3):1270-6. PubMed ID: 12133948 [TBL] [Abstract][Full Text] [Related]
6. Intragraft interleukin-4 mRNA expression after short-term CD154 blockade may trigger delayed development of transplant arteriosclerosis in the absence of CD8+ T cells. Ensminger SM; Spriewald BM; Witzke O; Morrison K; van Maurik A; Morris PJ; Rose ML; Wood KJ Transplantation; 2000 Sep; 70(6):955-63. PubMed ID: 11014649 [TBL] [Abstract][Full Text] [Related]
7. Modulation of costimulation by CD28 and CD154 alters the kinetics and cellular characteristics of corneal allograft rejection. Ardjomand N; McAlister JC; Rogers NJ; Tan PH; George AJ; Larkin DF Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):3899-905. PubMed ID: 12939307 [TBL] [Abstract][Full Text] [Related]
8. CD154 blockade alters innate immune cell recruitment and programs alloreactive CD8+ T cells into KLRG-1(high) short-lived effector T cells. Ferrer IR; Wagener ME; Song M; Ford ML PLoS One; 2012; 7(7):e40559. PubMed ID: 22792369 [TBL] [Abstract][Full Text] [Related]
9. Dependency of direct pathway CD4+ T cells on CD40-CD154 costimulation is determined by nature and microenvironment of primary contact with alloantigen. van Maurik A; Fazekas de St Groth B; Wood KJ; Jones ND J Immunol; 2004 Feb; 172(4):2163-70. PubMed ID: 14764682 [TBL] [Abstract][Full Text] [Related]
10. An anti-CD154 domain antibody prolongs graft survival and induces Foxp3(+) iTreg in the absence and presence of CTLA-4 Ig. Pinelli DF; Wagener ME; Liu D; Yamniuk A; Tamura J; Grant S; Larsen CP; Suri A; Nadler SG; Ford ML Am J Transplant; 2013 Nov; 13(11):3021-30. PubMed ID: 24007441 [TBL] [Abstract][Full Text] [Related]
11. Allograft rejection by primed/memory CD8+ T cells is CD154 blockade resistant: therapeutic implications for sensitized transplant recipients. Zhai Y; Meng L; Gao F; Busuttil RW; Kupiec-Weglinski JW J Immunol; 2002 Oct; 169(8):4667-73. PubMed ID: 12370407 [TBL] [Abstract][Full Text] [Related]
12. CD8 T cell-mediated rejection of intestinal allografts is resistant to inhibition of the CD40/CD154 costimulatory pathway. Guo Z; Meng L; Kim O; Wang J; Hart J; He G; Alegre ML; Thistlethwaite JR; Pearson TC; Larsen CP; Newell KA Transplantation; 2001 May; 71(9):1351-4. PubMed ID: 11403253 [TBL] [Abstract][Full Text] [Related]
13. Neutralizing IL-7 promotes long-term allograft survival induced by CD40/CD40L costimulatory blockade. Wang Y; Dai H; Liu Z; Cheng X; Tellides G; Dai Z Am J Transplant; 2006 Dec; 6(12):2851-60. PubMed ID: 17062001 [TBL] [Abstract][Full Text] [Related]
14. Two-signal blockade with anti-CD45RB and anti-CD154 monoclonal antibodies inhibits graft rejection via CD4-dependent mechanisms in allogeneic skin transplantation. Kim EY; Lee EN; Lee J; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Joh JW; Kim SJ Exp Mol Med; 2006 Jun; 38(3):284-94. PubMed ID: 16819287 [TBL] [Abstract][Full Text] [Related]
15. Critical role of CD4 help in CD154 blockade-resistant memory CD8 T cell activation and allograft rejection in sensitized recipients. Wu Z; Wang Y; Gao F; Shen X; Zhai Y; Kupiec-Weglinski JW J Immunol; 2008 Jul; 181(2):1096-102. PubMed ID: 18606661 [TBL] [Abstract][Full Text] [Related]
16. Prolonged islet graft survival in NOD mice by blockade of the CD40-CD154 pathway of T-cell costimulation. Molano RD; Berney T; Li H; Cattan P; Pileggi A; Vizzardelli C; Kenyon NS; Ricordi C; Burkly LC; Inverardi L Diabetes; 2001 Feb; 50(2):270-6. PubMed ID: 11272136 [TBL] [Abstract][Full Text] [Related]
17. Impact of both donor and recipient strains on cardiac allograft survival after blockade of the CD40-CD154 costimulatory pathway. van Maurik A; Wood KJ; Jones ND Transplantation; 2002 Sep; 74(5):740-3. PubMed ID: 12352896 [TBL] [Abstract][Full Text] [Related]
18. Effect of locally administered anti-CD154 (CD40 ligand) monoclonal antibody on survival of allogeneic corneal transplants. Qian Y; Dana MR Cornea; 2002 Aug; 21(6):592-7. PubMed ID: 12131037 [TBL] [Abstract][Full Text] [Related]
19. Critical role for CD8 T cells in allograft acceptance induced by DST and CD40/CD154 costimulatory blockade. Gao D; Lunsford KE; Eiring AM; Bumgardner GL Am J Transplant; 2004 Jul; 4(7):1061-70. PubMed ID: 15196062 [TBL] [Abstract][Full Text] [Related]
20. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis. Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]